DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

PLoS Genetics

Volumn 10, Issue 4, 2014, Pages

  Osorio, Ana ^a,b   Milne, Roger L ^c   Kuchenbaecker, Karoline ^d   Vaclová, Tereza ^a   Pita, Guillermo ^a   Alonso, Rosario ^a   Peterlongo, Paolo ^e   Blanco, Ignacio ^f   de la Hoya, Miguel ^g   Duran, Mercedes ^h   Díez, Orland ⁱ   Ramón y Cajal, Teresa ^j   Konstantopoulou, Irene ^k   Martínez Bouzas, Cristina ^l   Andrés Conejero, Raquel ^m   Soucy, Penny ⁿ   McGuffog, Lesley ^d   Barrowdale, Daniel ^d   Lee, Andrew ^d   Arver, Brita ^p   Rantala, Johanna ^p   Loman, Niklas ^q   Ehrencrona, Hans ^q   Olopade, Olufunmilayo I ^r   Beattie, Mary S ^s   Domchek, Susan M ^t   Nathanson, Katherine ^t   Rebbeck, Timothy R ^t   Arun, Banu K ^u   Karlan, Beth Y ^v   Walsh, Christine ^v   Lester, Jenny ^v   John, Esther M ^w   Whittemore, Alice S ^x   Daly, Mary B ^y   Southey, Melissa ^z   Hopper, John ^aa   Terry, Mary B ^ab   Buys, Saundra S ^ac   Janavicius, Ramunas ^ad   Dorfling, Cecilia M ^ae   van Rensburg, Elizabeth J ^ae   Steele, Linda ^af   Neuhausen, Susan L ^af   Ding, Yuan Chun ^af   Hansen, Thomas v O ^ag   Jønson, Lars ^ag   Ejlertsen, Bent ^ag   Gerdes, Anne Marie ^ag   Infante, Mar ^h   Herráez, Belén ^a   Moreno, Leticia Thais ^a   Weitzel, Jeffrey N ^af   Herzog, Josef ^af   Weeman, Kisa ^af   Manoukian, Siranoush ^ah   Peissel, Bernard ^ah   Zaffaroni, Daniela ^ah   Scuvera, Giulietta ^ah   Bonanni, Bernardo ^ai   Mariette, Frederique ^e   Volorio, Sara ^e   Viel, Alessandra ^aj   Varesco, Liliana ^ak   Papi, Laura ^al   Ottini, Laura ^am   Tibiletti, Maria Grazia ^an   Radice, Paolo ^ah   Yannoukakos, Drakoulis ^k   Garber, Judy ^ao   Ellis, Steve ^d   Frost, Debra ^d   Platte, Radka ^d   Fineberg, Elena ^d   Evans, Gareth ^ap   Lalloo, Fiona ^ap   Izatt, Louise ^aq   Eeles, Ros ^ar   Adlard, Julian ^as   Davidson, Rosemarie ^at   Cole, Trevor ^au   Eccles, Diana ^av   Cook, Jackie ^aw   Hodgson, Shirley ^ax   Brewer, Carole ^ay   Tischkowitz, Marc ^az   Douglas, Fiona ^ba   Porteous, Mary ^bb   Side, Lucy ^bc   Walker, Lisa ^bd   Morrison, Patrick ^be   Donaldson, Alan ^bf   Kennedy, John ^bg   Foo, Claire ^bh   Godwin, Andrew K ^bi   Schmutzler, Rita Katharina ^bj   Wappenschmidt, Barbara ^bj   Rhiem, Kerstin ^bj   Engel, Christoph ^bk   Meindl, Alfons ^bl   Ditsch, Nina ^bl   Arnold, Norbert ^bm   Plendl, Hans Jörg ^bm   Niederacher, Dieter ^bn   Sutter, Christian ^bo   Wang Gohrke, Shan ^bp   Steinemann, Doris ^bq   Preisler Adams, Sabine ^br   Kast, Karin ^bs   Varon Mateeva, Raymonda ^bt   Gehrig, Andrea ^bu   Stoppa Lyonnet, Dominique ^bv,bw,bx   Sinilnikova, Olga M ^by,bz   Mazoyer, Sylvie ^bz   Damiola, Francesca ^bz   Poppe, Bruce ^ca   Claes, Kathleen ^ca   Piedmonte, Marion ^cb   Tucker, Kathy ^cc   Backes, Floor ^cd   Rodríguez, Gustavo ^ce   Brewster, Wendy ^ce   Wakeley, Katie ^cf   Rutherford, Thomas ^cg   Caldés, Trinidad ^g   Nevanlinna, Heli ^ch   Aittomäki, Kristiina ^ch   Rookus, Matti A ^ci   van Os, Theo A M ^cj   van der Kolk, Lizet ^ci   de Lange, J L ^ci   Meijers Heijboer, Hanne E J ^ck   van der Hout, A H ^cl   van Asperen, Christi J ^cm   Gómez Garcia, Encarna B ^cn   Hoogerbrugge, Nicoline ^co   Collée, J Margriet ^cp   van Deurzen, Carolien H M ^cp   van der Luijt, Rob B ^cq   Devilee, Peter ^cm   Olah, Edith ^cs   Lázaro, Conxi ^f   Teulé, Alex ^f   Menéndez, Mireia ^f   Jakubowska, Anna ^ct   Cybulski, Cezary ^ct   Gronwald, Jacek ^ct   Lubinski, Jan ^ct   Durda, Katarzyna ^ct   Jaworska Bieniek, Katarzyna ^ct,cu   Johannsson, Oskar Th ^cv   Maugard, Christine ^cw   Montagna, Marco ^cx   Tognazzo, Silvia ^cx   Teixeira, Manuel R ^cy   Healey, Sue ^cz   Olswold, Curtis ^db   Guidugli, Lucia ^db   Lindor, Noralane ^dc   Slager, Susan ^db   Szabo, Csilla I ^dd   Vijai, Joseph ^de   Robson, Mark ^de   Kauff, Noah ^de   Zhang, Liying ^de   Rau Murthy, Rohini ^de   Fink Retter, Anneliese ^df   Singer, Christian F ^df   Rappaport, Christine ^df   Geschwantler Kaulich, Daphne ^df   Pfeiler, Georg ^df   Tea, Muy Kheng ^df   Berger, Andreas ^df   Phelan, Catherine M ^dg   Greene, Mark H ^dh   Mai, Phuong L ^dh   Lejbkowicz, Flavio ^di   Andrulis, Irene ^cr,dj   Mulligan, Anna Marie ^cr,da   Glendon, Gord ^dk   Toland, Amanda Ewart ^dl   Bojesen, Anders ^dm   Pedersen, Inge Sokilde ^dn   Sunde, Lone ^do   Thomassen, Mads ^dp   Kruse, Torben A ^dp   Jensen, Uffe Birk ^do   Friedman, Eitan ^dq   Laitman, Yael ^dq   Shimon, Shani Paluch ^dq   Simard, Jacques ^o   Easton, Douglas F ^d   Offit, Kenneth ^de   Couch, Fergus J ^db   Chenevix Trench, Georgia ^cz   Antoniou, Antonis C ^d   Benitez, Javier ^a,b   more..

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c CANCER EPIDEMIOLOGY CENTRE   (Australia)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^f CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^g HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^h UNIVERSITY OF VALLADOLID   (Spain)

ⁱ VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^j HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^k INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^l HOSPITAL DE CRUCES   (Spain)

^m HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

ⁿ LAVAL UNIVERSITY   (Canada)

^o UNIVERSITÉ LAVAL   (Canada)

^p KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^q LUND UNIVERSITY HOSPITAL   (Sweden)

^r UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^s UNIVERSITY OF CALIFORNIA   (United States)

^t UNIVERSITY OF PENNSYLVANIA   (United States)

^u UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^v CEDARS SINAI MEDICAL CENTER   (United States)

^w CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^x STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^y FOX CHASE CANCER CENTER   (United States)

^z UNIVERSITY OF MELBOURNE   (Australia)

^aa UNIVERSITY OF MELBOURNE   (Australia)

^ab Och Spine at New York Presbyterian Hospitals   (United States)

^ac UNIVERSITY OF UTAH   (United States)

^ad VILNIUS UNIVERSITY   (Lithuania)

^ae UNIVERSITY OF PRETORIA   (South Africa)

^af CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^ag UNIVERSITY OF COPENHAGEN   (Denmark)

^ah NATIONAL CANCER INSTITUTE   (Italy)

^ai EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^aj CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^ak UNIVERSITY OF GENOA   (Italy)

^al UNIVERSITY OF FLORENCE   (Italy)

^am SAPIENZA UNIVERSITY OF ROME   (Italy)

^an UNIVERSITY OF INSUBRIA   (Italy)

^ao DANA FARBER CANCER INSTITUTE   (United States)

^ap UNIVERSITY OF MANCHESTER   (United Kingdom)

^aq GUY S HOSPITAL   (United Kingdom)

^ar INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^as Yorkshire Regional Genetics Service   (United Kingdom)

^at ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^au BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^av PRINCESS ANNE HOSPITAL   (United Kingdom)

^aw SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^ax ST GEORGE S HOSPITAL   (United Kingdom)

^ay ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^az ADDENBROOKE S HOSPITAL   (United Kingdom)

^ba NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^bb WESTERN GENERAL HOSPITAL   (United Kingdom)

^bc GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^bd CHURCHILL HOSPITAL   (United Kingdom)

^be BELFAST CITY HOSPITAL   (United Kingdom)

^bf Sheffield Clinical Genetics Service Sheffield Children's Hospital ^*  (United Kingdom)

^bg ST JAMES S HOSPITAL   (Ireland)

^bh LIVERPOOL WOMEN'S NHS FOUNDATION TRUST   (United Kingdom)

^bi UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^bj University of Cologne   (Germany)

^bk UNIVERSITY OF LEIPZIG   (Germany)

^bl TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^bm UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^bn UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^bo UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^bp UNIVERSITY HOSPITAL ULM   (Germany)

^bq HANNOVER MEDICAL SCHOOL   (Germany)

^br UNIVERSITY OF MÜNSTER   (Germany)

^bs DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^bt CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^bu UNIVERSITY OF WÜRZBURG   (Germany)

^bv INSTITUT CURIE   (France)

^bw INSTITUT CURIE   (France)

^bx UNIVERSITÉ PARIS DESCARTES   (France)

^by HOSPICES CIVILS DE LYON   (France)

^bz CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^ca GHENT UNIVERSITY   (Belgium)

^cb ROSWELL PARK CANCER INSTITUTE   (United States)

^cc PRINCE OF WALES HOSPITAL   (Australia)

^cd OHIO STATE UNIVERSITY   (United States)

^ce NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^cf TUFTS MEDICAL CENTER   (United States)

^cg YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ch HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^ci NETHERLANDS CANCER INSTITUTE   (Netherlands)

^cj ACADEMIC MEDICAL CENTER   (Netherlands)

^ck VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^cl UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^cm LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^cn MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^co RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^cp ERASMUS MEDICAL CENTER   (Netherlands)

^cq UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^cr UNIVERSITY OF TORONTO   (Canada)

^cs NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^ct POMERANIAN MEDICAL UNIVERSITY   (Poland)

^cu MEDICAL UNIVERSITY OF WARSAW   (Poland)

^cv LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^cw HÔPITAL CIVIL   (France)

^cx VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^cy PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^cz QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^da UNIVERSITY HEALTH NETWORK   (Canada)

^db MAYO CLINIC   (United States)

^dc MAYO CLINIC   (United States)

^dd UNIVERSITY OF DELAWARE   (United States)

^de MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^df MEDICAL UNIVERSITY OF VIENNA   (Austria)

^dg H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^dh NATIONAL CANCER INSTITUTE   (United States)

^di CLALIT HEALTH SERVICES   (Israel)

^dj MOUNT SINAI HOSPITAL   (Canada)

^dk CANCER CARE ONTARIO   (Canada)

^dl OHIO STATE UNIVERSITY   (United States)

^dm LILLEBAELT HOSPITAL   (Denmark)

^dn AALBORG UNIVERSITY HOSPITAL   (Denmark)

^do AARHUS UNIVERSITY HOSPITAL   (Denmark)

^dp ODENSE UNIVERSITY HOSPITAL   (Denmark)

^dq SHEBA MEDICAL CENTER   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA GLYCOSYLTRANSFERASE; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN, HUMAN;

8 GUANINE DNA GLYCOSYLASE GENE; ADULT; APEX1 GENE; APEX2 GENE; ARTICLE; BREAST CANCER; CANCER RISK; DISEASE ASSOCIATION; ENDONUCLEASE VIII LIKE 2 GENE; EXCISION REPAIR; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LIG3 GENE; MAJOR CLINICAL STUDY; MBD4 GENE; MPG GENE; MUTYH GENE; NEIL1 GENE; NEIL2 GENE; NTHL1 GENE; OGG1 GENE; ONCOGENE; OVARY CANCER; PARP1 GENE; PARP2 GENE; PNKP GENE; POLB GENE; SEQUENCE TAGGED SITE; SINGLE NUCLEOTIDE POLYMORPHISM; SMUG1 GENE; TDG GENE; UNG GENE; XRCC1 GENE; ADOLESCENT; AGED; BREAST TUMOR; DNA REPAIR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; OVARY TUMOR; RISK; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA GLYCOSYLASES; DNA REPAIR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84901332067     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004256     Document Type: Article

References (42)

1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, et al. (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72: 1117-1130.
2. Chen S, Iversen ES, Friebel T, Finkelstein D, Weber BL, et al. (2006) Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol 24: 863-871.
3. Milne RL, Osorio A, Cajal TR, Vega A, Llort G, et al. (2008) The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Clin Cancer Res 14: 2861-2869.
4. Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, et al. (2007) An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 9: 104.
5. Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, et al. (2012) Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res 14: R33.
6. Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, et al. (2008) Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 82: 937-948.
7. Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, et al. (2009) Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 18: 4442-4456.
8. Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, et al. (2010) A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 42: 885-892.
9. Antoniou AC, Sinilnikova OM, Simard J, Leone M, Dumont M, et al. (2007) RAD51 135G→C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 81: 1186-1200.
10. Moynahan ME, Chiu JW, Koller BH, Jasin M, (1999) Brca1 controls homology-directed DNA repair. Mol Cell 4: 511-518.
11. Patel KJ, Yu VP, Lee H, Corcoran A, Thistlethwaite FC, et al. (1998) Involvement of Brca2 in DNA repair. Mol Cell 1: 347-357.
12. Xu G, Herzig M, Rotrekl V, Walter CA, (2008) Base excision repair, aging and health span. Mech Ageing Dev 129: 366-382.
13. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, et al. (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917-921.
14. Osorio A, Milne RL, Alonso R, Pita G, Peterlongo P, et al. (2011) Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. Br J Cancer 104: 1356-1361.
15. Zhang Y, Newcomb PA, Egan KM, Titus-Ernstoff L, Chanock S, et al. (2006) Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15: 353-358.
16. Zipprich A, Kuss O, Rogowski S, Kleber G, Lotterer E, et al. (2010) Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Gut 59: 963-968.
17. Popanda O, Seibold P, Nikolov I, Oakes CC, Burwinkel B, et al. (2013) Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk. Int J Cancer 132: 55-62.
18. Roberts MR, Shields PG, Ambrosone CB, Nie J, Marian C, et al. (2011) Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study. Carcinogenesis 32: 1223-1230.
19. Sangrajrang S, Schmezer P, Burkholder I, Waas P, Boffetta P, et al. (2008) Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Breast Cancer Res Treat 111: 279-288.
20. Ming-Shiean H, Yu JC, Wang HW, Chen ST, Hsiung CN, et al. (2010) Synergistic effects of polymorphisms in DNA repair genes and endogenous estrogen exposure on female breast cancer risk. Ann Surg Oncol 17: 760-771.
21. Zipprich J, Terry MB, Brandt-Rauf P, Freyer GA, Liao Y, et al. (2010) XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study. J Carcinog 9: 4.
22. Banerjee D, Mandal SM, Das A, Hegde ML, Das S, et al. (2011) Preferential repair of oxidized base damage in the transcribed genes of mammalian cells. J Biol Chem 286: 6006-6016.
23. Wei H, Kamat A, Chen M, Ke HL, Chang DW, et al. (2012) Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guerin. PLoS One 7: e38533.
24. Kinslow CJ, El-Zein RA, Rondelli CM, Hill CE, Wickliffe JK, et al. (2010) Regulatory regions responsive to oxidative stress in the promoter of the human DNA glycosylase gene NEIL2. Mutagenesis 25: 171-177.
25. Kinslow CJ, El-Zein RA, Hill CE, Wickliffe JK, Abdel-Rahman SZ, (2008) Single nucleotide polymorphisms 5′ upstream the coding region of the NEIL2 gene influence gene transcription levels and alter levels of genetic damage. Genes Chromosomes Cancer 47: 923-932.
26. Dey S, Maiti AK, Hegde ML, Hegde PM, Boldogh I, et al. (2012) Increased risk of lung cancer associated with a functionally impaired polymorphic variant of the human DNA glycosylase NEIL2. DNA Repair (Amst) 11: 570-578.
27. Zhai X, Zhao H, Liu Z, Wang LE, El-Naggar AK, et al. (2008) Functional variants of the NEIL1 and NEIL2 genes and risk and progression of squamous cell carcinoma of the oral cavity and oropharynx. Clin Cancer Res 14: 4345-4352.
28. Arcand SL, Provencher D, Mes-Masson AM, Tonin PN, (2005) OGG1 Cys326 variant, allelic imbalance of chromosome band 3p25.3 and TP53 mutations in ovarian cancer. Int J Oncol 27: 1315-1320.
29. Rossner P Jr, Terry MB, Gammon MD, Zhang FF, Teitelbaum SL, et al. (2006) OGG1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15: 811-815.
30. Wei W, He XF, Qin JB, Su J, Li SX, et al. (2012) Association between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis. Mol Biol Rep 39: 11249-11262.
31. Xie Y, Yang H, Miller JH, Shih DM, Hicks GG, et al. (2008) Cells deficient in oxidative DNA damage repair genes Myh and Ogg1 are sensitive to oxidants with increased G2/M arrest and multinucleation. Carcinogenesis 29: 722-728.
32. Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, et al. (2013) Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk. PLoS Genet 9: e1003212.
33. Visnes T, Akbari M, Hagen L, Slupphaug G, Krokan HE, (2008) The rate of base excision repair of uracil is controlled by the initiating glycosylase. DNA Repair (Amst) 7: 1869-1881.
34. Antoniou AC, Goldgar DE, Andrieu N, Chang-Claude J, Brohet R, et al. (2005) A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes. Genet Epidemiol 29: 1-11.
35. Gaudet MM, Kuchenbaecker KB, Vijai J, Klein RJ, Kirchhoff T, et al. (2013) Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk. PLoS Genet 9: e1003173.
36. Barnes DR, Lee A, Easton DF, Antoniou AC, (2012) Evaluation of association methods for analysing modifiers of disease risk in carriers of high-risk mutations. Genet Epidemiol 36: 274-291.
37. Barnes DR, Antoniou AC, (2012) Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers. J Intern Med 271: 331-343.
38. Amin N, van Duijn CM, Aulchenko YS, (2007) A genomic background based method for association analysis in related individuals. PLoS One 2: e1274.
39. Leutenegger AL, Prum B, Genin E, Verny C, Lemainque A, et al. (2003) Estimation of the inbreeding coefficient through use of genomic data. Am J Hum Genet 73: 516-523.
40. Delaneau O, Zagury JF, (2012) Haplotype inference. Methods Mol Biol 888: 177-196.
41. Howie BN, Donnelly P, Marchini J, (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5: e1000529.
42. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, et al. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26: 2336-2337.